ESSA Pharma Inc.·4

Mar 28, 12:39 PM ET

Sollis Gary 4

4 · ESSA Pharma Inc. · Filed Mar 28, 2024

Insider Transaction Report

Form 4
Period: 2024-03-25
Sollis Gary
Director
Transactions
  • Award

    Options

    2024-03-25+50,00050,000 total
    Exercise: $9.04From: 2025-03-25Exp: 2034-03-25Common Shares (50,000 underlying)

Documents

1 file
  • 4
    form4.xmlPrimary